The Health Economics & Health Technology Assessment (HEHTA) research group at the University of Glasgow has some spaces remaining on its live online course ***Maximising the Value of Clinical Trial Data: Advanced Analysis for Economic Evaluation and Modelling***

This course is a natural follow-on from advanced modelling courses and covers the fundamental concepts and practice of the key advanced analytic techniques that are required when determining appropriate approaches and estimating parameter values for cost-effectiveness models. It is also highly relevant to those seeking to improve the relevance of trial-based cost-effectiveness. It will be held using a blend of live, online 

[Mas ...]

En medio de la aceleración de la IA en multitud de ámbitos de la salud y, hasta cierto punto, deslumbrados por las ventajas y el avance que supone desde muchos puntos de vista, hay una mirada que también es interesante – y necesario – hacer: ¿Cómo encontrar el delicado equilibrio entre eficacia y ética? ¿Quién pone los límites y cómo se determinan? 

[Mas ...]

1) 3y Health Economist to assess the value of digital pathology, Queen Mary University of London, UK

*** 3-year Health Economist position at the Queen Mary University of London ***

We offer an exciting opportunity to join the Health Economics team led by Prof Boby Mihaylova at the Wolfson Institute of Population Health, the Queen Mary University of London, UK. 

[Mas ...]

Deadline Abstract Submission - MENTAL HEALTH SERVICES, ECONOMICS, POLICY RESEARCH - Venice, March 25-27, 2022

CALL FOR ABSTRACTS
Deadline Abstract Submission: OCTOBER 30, 2021

Fifteenth Workshop on Costs and Assessment in Psychiatry
MENTAL HEALTH SERVICES, ECONOMICS, POLICY RESEARCH
Venice, Scuola Grande di San Giovanni Evangelista, March 25-27, 2022

The Workshop, sponsored by the World Psychiatric Association (WPA), Section on Mental Health Economics,
considers the crucial research areas of mental health services, economics and public health research,
including the relationships of COVID-19 pandemic and mental illness. 

[Mas ...]

We hope you will join us for the virtual 2021 OHE Annual Lecture with Professor Margaret Kyle on Thursday, October 14th at 13:00-15:00

Professor Kyle will answer the critical question “Do patents work?” focusing on evidence from pharmaceutical innovation.

Register for free: https://www.eventbrite.co.uk/e/do-patents-work-evidence-from-pharmaceutical-innovation-tickets-180941028487

Patents, once the “no brainer” of the innovation model, are being questioned. The exceptional circumstances of COVID-19 revived the controversy around patents of pharmaceutical products. It has been suggested that the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement should be waived to provide quick access to COVID-19 to low- and middle-income countries. Those opposing the waiver 

[Mas ...]

A reminder that the deadline for submission of abstracts for the January 2022 HESG meeting in Leeds is on Friday the 8th October 2021. Please submit abstracts using the following website:https://hesg.org.uk/meetings/abstract-submission/

The meeting will be held face to face from 5th January to 7th January 2022 and hosted by the University of Leeds. Please put this into your diaries now! 

[Mas ...]

Próxima edición del MÁSTER UNIVERSITARIO EN ATENCIÓN INTEGRADA EN LA CRONICIDAD Y EL ENVEJECIMENTO (MUAICE) DE LA UNIVERSITAT POMPEU FABRA

NOVEDADES DE ESTA EDICIÓN
Modalidad: Semipresencial a tiempo parcial
Días de impartición: viernes mañanas de 8 a 15 horas
*Dos viernes con actividades en el aula y dos viernes en actividades virtuales en streaming
Duración: De Enero 2022 a Junio 2023 (dividido en dos cursos académicos) 

[Mas ...]

We're delighted to announce the launch of our fully virtual 2021 Masterclass Series, Demonstrating Value: Evolving with Innovation, starting on Tuesday 30 March.

The Series comprises five half-day events scheduled for a global audience.

THE THEME
Broader value of treatments and vaccines have been acknowledged at the height of the pandemic and it is critical that, in the post-pandemic recovery period, this continues to be recognised. For this to happen, there is a need for a shared understanding of what constitutes value, capturing what matters most to patients, society, and payers. Get the support and evidence you need to build 

[Mas ...]